Mammoth Biosciences to Present at the 2023 Annual Meeting of the American Society of Gene and Cell T
Presentation will highlight the capability and advances of Mammoth’s ultracompact CRISPR systemsBRISBANE, Calif.--(BUSINESS WIRE)--#ASGCT2023--Mammoth Biosciences, a biotechnology company harnessing its proprietary next-generation CRISPR platform to create potential one-time curative therapies, today announced Janic...
Source: pharmiweb.com